SweetValueLab
Write for us

The Cooper Companies, Inc. — Wall Street Analyst Estimates & Price Targets

COO
NASDAQHealthcareMedical - Instruments & SuppliesCIK 0000711404coopercos.comAbout COO
Last close · Oct 16, 202657.94+0.54 (+0.94%)
Market cap$11.0B

8 firms' latest targets, last 90 days: median $63.50 ($59.00–$75.00), 10% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker
$60.0$80.0$100NovJan 2026MarMayJulSep2025-12-05 · Baird: $98.02025-12-05 · Mizuho Securities: $1002025-12-05 · Stifel: $95.02025-12-05 · Piper Sandler: $94.02025-12-05 · Needham: $1002025-12-08 · Goldman Sachs: $71.02025-12-08 · Barclays: $91.02026-01-09 · Goldman Sachs: $73.02026-01-26 · Barclays: $98.02026-02-03 · Needham: $99.02026-05-27 · Goldman Sachs: $61.02026-06-01 · Piper Sandler: $86.02026-06-04 · Mizuho Securities: $85.02026-06-05 · Needham: $86.02026-06-05 · Wells Fargo: $66.02026-09-10 · Mizuho Securities: $75.02026-09-10 · UBS: $66.02026-09-10 · Needham: $73.02026-09-10 · Wells Fargo: $61.02026-09-10 · Stifel: $70.02026-09-10 · Baird: $61.02026-09-10 · Piper Sandler: $59.02026-10-06 · Barclays: $60.0
$60.0$80.0$100NovFebMayAug

Each firm's latest target

last 90 days · 8 firms
DateFirmTargetPreviousChangeVs price thenVs price now
2026-10-06Barclays$60.00$98.00▼ 39%+6%+4%
2026-09-10Mizuho Securities$75.00$85.00▼ 12%+36%+29%
2026-09-10UBS$66.00——+4%+14%
2026-09-10Needham$73.00$86.00▼ 15%+15%+26%
2026-09-10Wells Fargo$61.00$66.00▼ 8%-4%+5%
2026-09-10Stifel$70.00$95.00▼ 26%+10%+21%
2026-09-10Baird$61.00$98.00▼ 38%-4%+5%
2026-09-10Piper Sandler$59.00$86.00▼ 31%-7%+2%

Consensus estimates

revenue and EPS by fiscal year · reported years marked
FYRevenueYoYEPSYoYRevenue rangeEPS rangeAnalysts
2023reported$3.6B+9%$1.48-24%est. $3.6B+0%est. $3.2012
2024reported$3.9B+8%$1.96+33%est. $3.9B+0%est. $3.6617
2025reported$4.1B+5%$1.87-5%est. $4.1B+0%est. $4.1011
2026$4.2B+4%$4.54+11%$4.2B–$4.2B$4.53–$4.5513
2027$4.4B+4%$4.70+4%$4.4B–$4.4B$4.56–$4.8913
2028$4.6B+5%$5.11+9%$4.5B–$4.7B$4.40–$5.7513
2029$4.9B+5%$5.53+8%$4.8B–$4.9B$5.45–$5.596
2030$5.2B+7%$6.12+11%$5.1B–$5.2B$6.03–$6.189
A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.